Completed NA INTERVENTIONAL 1-arm NCT02634060

Home basEd faecaL calProtectin Measurements Predicting Adalimumab Induction Destiny (HELP-AID)

Sponsor: Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZW

Conditions Colitis, Ulcerative Crohn Disease

Interventions Home Based Fecal Calprotectin

Updated 9 times since 2017 Last updated: Jun 26, 2024 Started: Mar 31, 2016 Primary completion: Jun 1, 2018 Completion: Sep 5, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Colitis, Ulcerative and Crohn Disease and is currently completed. Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZW leads this study, which shows 9 recorded versions since 2016 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA

Status: Unknown Status → Completed
Nov 2022 — Jul 2024 [monthly]

Unknown Status NA
Jan 2021 — Nov 2022 [monthly]

Unknown Status NA
Feb 2020 — Jan 2021 [monthly]

Unknown Status NA

▶ Show 4 earlier versions

Nov 2019 — Feb 2020 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jun 2018 — Nov 2019 [monthly]

Recruiting NA
Feb 2017 — Jun 2018 [monthly]

Recruiting NA
Jan 2017 — Feb 2017 [monthly]

Recruiting NA

First recorded

Mar 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZW
Universitaire Ziekenhuizen KU Leuven

Data source: Universitaire Ziekenhuizen KU Leuven

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Leuven, Belgium